$IDXX News

IDEXX Parasite Test Expansion Links Zoonotic Risk And Valuation Debate

IDEXX Laboratories Touts AI Push, inVue Dx Momentum at Stifel Conference

IDEXX Laboratories (IDXX) Embeds an Early Kidney Disease Detector Into Its Most Popular Test Profile

IDEXX Laboratories, Inc. (IDXX) Presents at Stifel Jaws & Paws Conference 2026 Transcript

Is Wall Street Bullish or Bearish on IDEXX Laboratories Stock?

IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection

Should IDEXX’s (IDXX) SDMA-Enhanced Catalyst Panels Prompt Action From Long-Term Diagnostics Investors?

IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles

Capitalizing On Growth Prospects, Irene Chang Britt Acquires IDEXX Laboratories Stock Options Worth $771

Bruce L Claflin Backs Up Beliefs With A Notable Acquisition Of IDEXX Laboratories Stock Options Worth $771

In A Strategic Move, Joseph L Hooley Acquires IDEXX Laboratories Stock Options Worth $771: Enhancing Value

Karen Peacock At IDEXX Laboratories Exercises Options Worth $0

Engaging In Insider Activity, Sam Samad At IDEXX Laboratories Exercises Options Worth $0

IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day

Do You Believe in the Long-Term Growth Potential of IDEXX Laboratories (IDXX)?

BofA Sees Slower InVue Installations as Headwind for IDEXX Laboratories, Inc. (IDXX)

Analyst Estimates: Here's What Brokers Think Of IDEXX Laboratories, Inc. (NASDAQ:IDXX) After Its First-Quarter Report

IDEXX Laboratories Q1 Earnings Call Highlights

IDEXX Laboratories, Inc. Q1 2026 Earnings Call Summary

Idexx (IDXX) Q1 2026 Earnings Call Transcript